Biio-Medical Applications Of Texas, Inc. is a medicare approved dialysis facility center in Lockhart, Texas and it has 15 dialysis stations. It is located in Caldwell county at 1721 S Colorado St, Lockhart, TX, 78644. You can reach out to the office of Biio-Medical Applications Of Texas, Inc. at (512) 398-6357. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Biio-Medical Applications Of Texas, Inc. has the following ownership type - Profit. It was first certified by medicare in August, 2017. The medicare id for this facility is 672818 and it accepts patients under medicare ESRD program.
Name | Biio-Medical Applications Of Texas, Inc. |
---|---|
Location | 1721 S Colorado St, Lockhart, Texas |
No. of Dialysis Stations | 15 |
Medicare ID | 672818 |
Managed By | Fresenius Medical Care |
Ownership Type | Profit |
Late Shifts | No |
1721 S Colorado St, Lockhart, Texas, 78644 | |
(512) 398-6357 | |
Not Available |
NPI Number | 1578958302 |
Organization Name | Fresenius Medical Care Lockhart |
Doing Business As | Bio-medical Applications Of Texas, Inc. |
Address | 1721 S. Colorado Street Lockhart, Texas, 78644 |
Phone Number | (512) 398-6357 |
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 5 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 29 |
Percentage of adult patients getting regular hemodialysis at the center | |
Percentage of pediatric patients getting regular hemodialysis at the center |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Biio-Medical Applications Of Texas, Inc. with elevated calcium levels.
Patients with hypercalcemia | 6 |
Hypercalcemia patient months | 32 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
Patients with Serumphosphor | 5 |
Patients with Serumphosphor less than 3.5 mg/dL | |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
Patients with Serumphosphor from 5.6 to 7 mg/dL | |
Patients with Serumphosphor greater than 7 mg/dL |
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 9 |
Patient months included in arterial venous fistula and catheter summaries | 9 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
Biio-Medical Applications Of Texas, Inc. Location: 1721 S Colorado St, Lockhart, Texas, 78644 Phone: (512) 398-6357 |
Meramec Dialysis, Llc Location: 1806 South Colorado Street, Lockhart, Texas, 78644 Phone: (512) 398-6419 |